Monthly Archives: February 2017

Pennside Partners Welcomes New European Director

2020-03-02T20:07:57+00:00February 20th, 2017|Categories: News|Tags: |

Pennside Partners extends a warm welcome to Tom Perkins, who has been hired as a Director based out of our Zurich office. Tom brings 14 years of pharmaceutical consulting experience to Pennside. Tom is joining Pennside after more than a decade with leading market research firm, GfK. He began his pharma career first as an intern at V2 (acquired by GfK) during his studies at St. Joseph’s University (Philadelphia, PA, [...]

7 Top Pharma Trends for 2017

2020-02-28T14:57:01+00:00February 7th, 2017|Categories: Blog|Tags: , , |

From the effects of Donald Trump’s election as US president to pioneering therapies for Alzheimer’s, some trends are set to continue and others to emerge as the global pharmaceutical industry pushes into 2017. Analyzing the top seven pharma trends forecast for the new year, Pennside Partners offers some key insights into the essentials. Pharma Trend #1: High-tech pharma With inhalers that track doses and products that monitor patient compliance, [...]